AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., (2014) 457 F.T.R. 227 (FC)

This document cites

• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• Pfizer Canada Inc. et al. v. Novopharm Ltd. et al., (2012) 436 N.R. 299 (SCC)
• JAY-LOR International Inc. et al. v. Penta Farm Systems Ltd. et al., (2007) 313 F.T.R. 1 (FC)
• Danyluk v. Ainsworth Technologies Inc. et al., 2001 SCC 44
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2000) 262 N.R. 137 (FCA)



See all quotations

• Eli Lilly Canada Inc. v. Apotex Inc. et al., 2009 FCA 97
• Toronto (City) v. Canadian Union of Public Employees, Local 79 et al., (2003) 179 O.A.C. 291 (SCC)
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 366 N.R. 347 (FCA)
• Rothmans, Benson & Hedges Inc. et al. v. Imperial Tobacco Ltd., (1993) 152 N.R. 292 (FCA)
• Signalisation de Montréal Inc. v. Services de Béton Universels ltée et al., (1992) 147 N.R. 241 (FCA)
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Apotex Inc. v. Sanofi-Aventis, (2013) 447 N.R. 313 (FCA)
• Bayer AG et al. v. Apotex Inc. et al., 2007 FCA 243
• Monsanto Co. v. Commissioner of Patents, (1979) 28 N.R. 181 (SCC)
• Toronto (City) v. Canadian Union of Public Employees, Local 79 et al., (2003) 311 N.R. 201 (SCC)
• Janssen-Ortho Inc. et al. v. Novopharm Ltd., 2007 FCA 217
• Shire Biochem Inc. et al. v. Canada (Minister of Health) et al., (2008) 328 F.T.R. 123 (FC)
• AstraZeneca Canada Inc. et al. v. Teva Canada Ltd. et al., (2013) 428 F.T.R. 269 (FC)
• Eli Lilly & Co. et al. v. Apotex Inc., (2009) 351 F.T.R. 1 (FC)
• R. v. Henry (D.B.) et al., (2005) 342 N.R. 259 (SCC)
• R. v. Henry (D.B.) et al., (2005) 219 B.C.A.C. 1 (SCC)
• Apotex Inc. v. Pfizer Ireland Pharmaceuticals, 2011 FCA 77
• R. v. Henry (D.B.) et al., (2005) 376 A.R. 1 (SCC)
• AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., 2011 FC 1023
• Bristol-Myers Squibb Canada Co. et al. v. Apotex Inc. et al., (2009) 342 F.T.R. 161 (FC)
• Pfizer Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., 2011 FC 547
• AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., 2010 FC 714
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2001) 266 N.R. 371 (FCA)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., 2011 FCA 236
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2002) 296 N.R. 130 (SCC)
• Consolboard Inc. v. MacMillan Bloedel (Saskatchewan) Ltd., (1981) 35 N.R. 390 (SCC)
• Novopharm Ltd. v. Eli Lilly & Co., (2011) 420 N.R. 188 (FCA)
• Eli Lilly Canada Inc. et al. v. Novopharm Ltd., (2010) 405 N.R. 1 (FCA)
• Merck & Co. et al. v. Pharmascience Inc. et al., (2010) 368 F.T.R. 1 (FC)